Buy or sell Curebase stock pre IPO via an EquityZen fund
Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.
About Curebase Stock
Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. The company was established in 2017 and is based in San Francisco, California.
Founder & CEO
Vice President Of Business Development
Chief Operating Officer
TechCrunch - Aug, 22 2018